Hyperbiotics
Pro-Dental chewable tablets using clinically studied strains to lessen plaque build-up across the mouth and digestive tract.
- Country
- United States
Commercial
Pro-Dental chewable tablets; clinically studied strains targeting oral + digestive tract; reduces plaque build-up
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Probiotic oral care | specialty-fine-chem | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.